Johns Hopkins University partners with Medopad to use AI

Charlotte Edwards 22 January 2018 (Last Updated January 22nd, 2018 09:51)

Johns Hopkins University will be developing new clinical and health innovations after signing a memorandum of understanding with health technology company Medopad. The agreement will enable the university to make use of the digital health leader’s patient monitoring platform, artificial intelligence and machine learning capabilities, allowing it to apply these techniques to its new global mental health initiative.

Johns Hopkins University partners with Medopad to use AI
Johns Hopkins University Campus. Credit: Tim Rawle

Johns Hopkins University will be developing new clinical and health innovations after signing a memorandum of understanding with health technology company Medopad. The agreement will enable the university to make use of the digital health leader’s patient monitoring platform, artificial intelligence and machine learning capabilities, allowing it to apply these techniques to its new global mental health initiative.

The two organisations plan to work on joint clinical and public health projects.

Dr. Alain Labrique, Director of the Johns Hopkins University Global mHealth Initiative said: “We look forward to enriching this burgeoning engagement between our two institutions, strengthening this academic-private sector collaboration through rigorous research and clinical innovation to improve lives around the globe.”

Dr. Paul Nagy, Deputy Director of the Johns Hopkins Medicine Technology Innovation Center added: “We’re excited to see what the future holds for public health and technology at Johns Hopkins with Medopad, a global leader in patient engagement. Medopad’s expertise and track record speaks volumes about the potential for even more impactful and valuable innovations for delivering better patient care.”

The collaboration will see the institutions aim to predict analysis for at risk patients, support existing clinical worker and staff with decisions, use population health monitoring to identify outbreaks and epidemics, offer dashboards with educational content and discover gaps in care or patient needs.

Dan Vahdat, co-founder and CEO at Medopad said: “We are delighted to work alongside Johns Hopkins – a prestigious, globally renowned institution. By combining our resources and expertise we will be able to create innovative mobile health solutions and improve patient care on a global scale.”

Access to sophisticated artificial intelligence engines, advanced analytics and large existing data sets are necessary for John Hopkins to continue its Global mHealth Initiative. The university said the project aims to ‘develop responsive innovations and provide rigorous, evidence-based support for mobile ICTs to improve global health’.